[Clinical studies on the effect of a new oral antidiabetic agent Glybenclamide (HB 419)].
D000367:Age Factors; D000368:Aged; D001645:Biguanides / Q000008:administration & dosage; D001786:Blood Glucose; D003920:Diabetes Mellitus / Q000188:drug therapy*; D004361:Drug Tolerance; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D013997:Time Factors; D014044:Tolbutamide / Q000008:administration & dosage
D001645:Biguanides; D001786:Blood Glucose; D007004:Hypoglycemic Agents; D014044:Tolbutamide
Klinische Untersuchungen zur Wirksamkeit des neuen oralen Antidiabetikums Glybenclamid (HB 419)